PICONI, STEFANIA
 Distribuzione geografica
Continente #
EU - Europa 2.604
NA - Nord America 2.298
AS - Asia 1.914
SA - Sud America 218
AF - Africa 88
OC - Oceania 5
Totale 7.127
Nazione #
US - Stati Uniti d'America 2.162
GB - Regno Unito 879
CN - Cina 656
SG - Singapore 631
IT - Italia 518
DE - Germania 305
SE - Svezia 195
HK - Hong Kong 172
RU - Federazione Russa 167
BR - Brasile 154
IN - India 145
CA - Canada 116
NL - Olanda 90
UA - Ucraina 89
FR - Francia 83
FI - Finlandia 75
IE - Irlanda 73
TR - Turchia 64
VN - Vietnam 59
KR - Corea 54
CI - Costa d'Avorio 32
CO - Colombia 28
EU - Europa 26
PL - Polonia 26
ES - Italia 24
ID - Indonesia 22
JP - Giappone 19
ZA - Sudafrica 16
AT - Austria 14
BE - Belgio 14
SA - Arabia Saudita 14
AR - Argentina 12
DK - Danimarca 12
MX - Messico 12
IQ - Iraq 11
EG - Egitto 10
BD - Bangladesh 9
GR - Grecia 9
CH - Svizzera 7
CL - Cile 7
PK - Pakistan 7
TW - Taiwan 7
MA - Marocco 6
AU - Australia 5
EC - Ecuador 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
DZ - Algeria 4
GH - Ghana 4
JO - Giordania 4
PT - Portogallo 4
PY - Paraguay 4
VE - Venezuela 4
BG - Bulgaria 3
CY - Cipro 3
IL - Israele 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
KE - Kenya 2
KW - Kuwait 2
NP - Nepal 2
PA - Panama 2
TH - Thailandia 2
TZ - Tanzania 2
ZW - Zimbabwe 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GI - Gibilterra 1
GL - Groenlandia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
Totale 7.149
Città #
Southend 801
Singapore 317
Dallas 273
Chandler 205
Ashburn 203
Milan 181
Beijing 154
Hong Kong 152
Seattle 94
Princeton 85
Frankfurt am Main 80
Jacksonville 74
Toronto 74
Wilmington 74
Dublin 73
Ann Arbor 63
Dearborn 58
Hefei 57
Los Angeles 57
San Jose 57
Council Bluffs 54
Bengaluru 49
Fairfield 46
Pisa 45
Santa Clara 45
Nanjing 40
Columbus 35
Helsinki 34
Mountain View 33
Abidjan 32
Shanghai 32
Somerville 32
Redmond 31
Hanover 30
Serra 30
Boardman 28
Houston 28
Jinan 28
Moscow 28
Redwood City 26
Guangzhou 24
Bogotá 23
Cambridge 23
Ottawa 23
Sakarya 23
Woodbridge 22
Andover 21
Jakarta 21
Warsaw 21
Buffalo 20
Des Moines 20
Margão 20
Munich 20
Rome 19
Ho Chi Minh City 18
Phoenix 17
Shenyang 16
The Dalles 16
Chicago 15
São Paulo 15
Brussels 14
Eitensheim 14
Amsterdam 13
Falls Church 13
Hanoi 13
Nashville 13
New York 13
Tokyo 13
Berlin 12
Naples 12
Tianjin 12
Cangzhou 10
Fuzhou 10
Madrid 10
Nanchang 10
Pune 10
Vienna 10
Ankara 9
Hangzhou 9
Kunming 9
Nuremberg 9
Seoul 9
Turku 9
Capriate San Gervasio 8
Grafing 8
Istanbul 8
Mumbai 8
Turin 8
Changsha 7
Chennai 7
Denver 7
London 7
San Diego 7
Tappahannock 7
Dammam 6
Lappeenranta 6
Orem 6
Paris 6
Riyadh 6
Valencia 6
Totale 4.609
Nome #
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders 521
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 235
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals 220
A role for mucosal immunity in resistance to HIV infection 212
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients 208
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals 203
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial 201
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy 196
HIV/AIDS : epidemic update, new treatment strategies and impact on autoimmunity 194
A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus 193
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 192
Type 1 and type 2 cytokines in HIV infection: a possible role in apoptosis and disease progression 191
Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis 179
Immunological effects of sublingual immunotherapy : clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4 178
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or -treated individuals 170
Immunological effects of omalizumab in chronic urticaria : a case report 161
Immune activation in HIV-infected African individuals 160
Myalgia, Obtundity and Fever in a Patient with a Prosthesis 160
Acute respiratory distress syndrome in adenovirus type 4 pneumonia : a case report 159
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 159
Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project 157
Surgical site infections in liver transplantation in the era of multidrug-resistant bacteria 156
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons 155
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 152
Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid 150
Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production 150
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis 150
Immune profiles of patients with chronic idiopathic urticaria 148
Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection 146
Vaccine strategies for infectious diseases 140
Fever, edema, and shortness of breath : the Scrhödinger’s cat paradox displayed on pericardium 140
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study [J Antimicrob Chemother, 72, (2017) (2879-2886)] DOI: 10.1093/jac/dkx169 137
Intractable pruritus in HIV infection : immunologic characterization 133
Negativepressure wound treatment of infections caused by extensively drug-resistant gram-negative bacteria after liver transplantation : two case reports 129
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects 126
Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41 125
Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C 125
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 122
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 120
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 108
Disseminated cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak 89
Efficacy and Safety of Ceftazidime-Avibactam Alone versus Ceftazidime-Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 88
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 83
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 82
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 63
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 61
Adult-Onset Still Disease After Human Herpesvirus 6 Infection in an Elderly Patient: A Case Report 50
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 24
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 21
[Recommendations for the prevention of infective endocarditis in patients undergoing cardiovascular interventions] Linee di indirizzo per la prevenzione dell’endocardite infettiva nei pazienti sottoposti a interventi cardiovascolari 15
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 12
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry 1
Totale 7.450
Categoria #
all - tutte 19.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 39 35 57 26 94 22
2021/2022608 62 44 6 38 26 23 55 39 107 55 66 87
2022/2023667 83 86 49 64 81 134 7 63 50 8 38 4
2023/2024466 18 39 37 39 73 44 27 32 10 36 41 70
2024/20251.177 41 99 21 96 66 59 45 127 68 117 116 322
2025/20261.877 272 252 423 310 289 229 102 0 0 0 0 0
Totale 7.450